跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
A-277
首页
药物
A-277
A-277
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Chinese medicinal compound preparation for treating liver fibrillation disease and its preparation method
申请人: YANGZIJIANG PHARMACEUTICAL IND
优先权: 2003
CN
Schistosoma japonicum miRNA simulant capable of inducing hepatic stellate cell apoptosis and application of schistosoma japonicum miRNA simulant
申请人: SHANGHAI VETERINARY RES INST CHINESE ACADEMY AGRICULTURAL SCIENCES CHINA CT ANIMAL
优先权: 2025
CN
Qi shu hemostasis and flooding prevention traditional Chinese medicine, and preparation method and quality detection technology thereof
申请人: HEFEI CHUANGXIN MEDICAL TECHNOLOGY CO LTD
优先权: 2013
CN
BACTERIOPHAGE EXHIBITING BROAD ANTIBACTERIAL SPECTRUM AGAINST ESCHERICHIA COLI
申请人: UNIV WASEDA
优先权: 2024
WO
USES OF CHK2 INHIBITORS
申请人: UNIV BIRMINGHAM
优先权: 2020
CN
US
2 件公开
Treatment of ocular conditions
申请人: UNIV BIRMINGHAM
优先权: 2020
CN
RNAI PREPARATION INHIBITING XDH GENE EXPRESSION AND USE THEREOF
申请人: MABWELL SHANGHAI BIOSCIENCE CO LTD
优先权: 2024
CN
WO
2 件公开
PROBIOTIC COMPOSITION FOR TREATING PICORNAVIRUS INFECTION AND ITS USE THEREOF
申请人: GENMONT BIOTECH INC
优先权: 2013
US
药物
反馈